Page last updated: 2024-09-03

tazobactam and ppi-0903

tazobactam has been researched along with ppi-0903 in 4 studies

Compound Research Comparison

Studies (tazobactam)	Trials (tazobactam)	Recent Studies (post-2010) (tazobactam)	Studies (ppi-0903)	Trials (ppi-0903)	Recent Studies (post-2010) (ppi-0903)
1,327	153	694	519	39	451

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	3 (75.00)	2.80

Authors

Authors	Studies
Rademacher, J; Welte, T	1
Anguita-Santos, F; Aznarte-Padial, MP; Borreguero, I; Castón, JJ; Corzo-Delgado, JE; Esteban-Moreno, MÁ; Herrero-Rodríguez, C; Jiménez-Aguilar, P; López-Cárdenas, S; Maldonado, N; Martín-Aspas, A; Martínez-Marcos, FJ; Ojeda-Burgos, G; Palacios-Baena, ZR; Praena-Segovia, J; Retamar, P; Rodríguez-Baño, J; Rosso-Fernández, CM; Valiente de Santis, L	1
Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A	1
Cheng, B; Guo, P; Jia, P; Xu, Y; Yang, Q; Zhang, H; Zhu, Y	1

Reviews

2 review(s) available for tazobactam and ppi-0903

Article	Year
[New antibiotics - standstill or progress]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ephedrine; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Penicillanic Acid; Phenobarbital; Staphylococcal Infections; Tazobactam; Theophylline; Triazoles	2017
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors? Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam	2020

Article

Year

[New antibiotics - standstill or progress].

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:3

Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ephedrine; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Penicillanic Acid; Phenobarbital; Staphylococcal Infections; Tazobactam; Theophylline; Triazoles

2017

Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?

Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam

2020

Other Studies

2 other study(ies) available for tazobactam and ppi-0903

Article	Year
Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project. BMJ open, 2020, 07-31, Volume: 10, Issue:7 Topics: Antimicrobial Stewardship; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Protocols; Drug Combinations; Humans; Interrupted Time Series Analysis; Medication Systems; Oxazolidinones; Practice Patterns, Physicians'; Spain; Tazobactam; Teicoplanin; Tetrazoles	2020
In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program. BMC microbiology, 2022, 10-01, Volume: 22, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline	2022

Article

Year

Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project.

BMJ open, 2020, 07-31, Volume: 10, Issue:7

Topics: Antimicrobial Stewardship; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Protocols; Drug Combinations; Humans; Interrupted Time Series Analysis; Medication Systems; Oxazolidinones; Practice Patterns, Physicians'; Spain; Tazobactam; Teicoplanin; Tetrazoles

2020

In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.

BMC microbiology, 2022, 10-01, Volume: 22, Issue:1

Topics: Ampicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline

2022